Mixed Connective Tissue Disease Clinical Trials
2 recruiting trials for Mixed Connective Tissue Disease. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Mixed Connective Tissue Disease clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Louisiana State University Health Sciences Center in New Orleans (1), Yale University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is No intervention. Biospecimen collection only (other, 1 trial).
Track Mixed Connective Tissue Disease trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
New Orleans Pulmonary Hypertension Biobank
Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care,...
Rheumatology Patient Registry and Biorepository
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Mixed Connective Tissue Disease, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Mixed Connective Tissue Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Mixed Connective Tissue Disease, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.